Discovering a Breakthrough: Gilead’s Long-Standing Commitment to Helping Change the Course of HIV
NORTHAMPTON, MA / ACCESS Newswire / April 1, 2025 / In 2006, Tomas Cihlar knew all too well that despite initial successes ...
1 Healthcare Stock to Target This Week and 2 to Turn Down
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term ...
Healthline5d
The Evolution of HIV Treatments
Many treatments can help people with HIV live longer, more fulfilling lives. The main treatment for HIV is antiretroviral medication. Every year, researchers are investigating new therapies in the ...
pharmaphorum4d
FDA approves Merck’s Delstrigo and Pifeltro for HIV treatment
Merck announced that the US regulators, Food and Drug Administration (FDA) has approved two new HIV-1 medicines: Delstrigo and Pifeltro.
Medical News Today22d
Descovy for PrEP
Descovy (emtricitabine/tenofovir alafenamide) is a brand-name oral tablet prescribed for preexposure prophylaxis (PrEP) in certain people at risk of developing HIV. Descovy also treats HIV in ...
Medscape16d
Two-Drug HIV Regimen Matches Standard of Care Therapy in Absence of Drug Resistance Testing
Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with HIV without preliminary drug resistance testing in a phase 4 trial.